• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Baby Care Product Specification Sheet: What Should Procurement Agree Before Issuing a Purchase Order?

A purchase order is a financial commitment; the specification sheet is the technical contract behind it. In mom and baby care, the cost of an incomplete spec sheet is higher than in adult categories,…

Category: Mom & Baby Care Sourcing Guides • Author: laeyo • Published: 2026-11-01 • Views: 86

A purchase order is a financial commitment; the specification sheet is the technical contract behind it. In mom and baby care, the cost of an incomplete spec sheet is higher than in adult categories, because the margin for irritation, microbial risk, and claim overreach is narrower — and because the buyer, not the factory, owns the claim on the label. This guide sets out the parameters procurement should agree, in writing, before the PO is issued, and the evidence that proves each one is real rather than assumed.

Informational only, not legal advice. Market-specific requirements must be confirmed with your regulatory responsible person before filing or label release.

What a PO-ready specification sheet must settle

  • Market and product classification come first. Rinse-off vs. leave-on, baby vs. child use, and the first-sale country determine microbial limits, preservative strategy, labeling, and which claims are even reviewable. If the market is undecided, the specification cannot be final.
  • Three decisions carry the most leverage: (1) the preservative and microbiological target, (2) the safety/irritation test package that supports your claims, and (3) the primary packaging route (stock, semi-custom, or custom mold). Change any one of these after the PO and you re-open stability, compatibility, and label artwork.
  • Lock the irreversible items first — formula version, preservative system, packaging combination ID, and market. Optimize cost, decoration, and secondary packaging later; they can be re-quoted without invalidating the test data.
  • Never issue a PO on a verbal spec. A signed product specification, a packaging BOM with a combination approval number, and a claim matrix with evidence IDs are the minimum attachments.
  • Request five things immediately: product specification sheet (versioned), COA template plus one real batch COA, preservative efficacy and microbiological test reports for the exact formula version, packaging compatibility and leak report for the exact container-closure combination, and the claim support file for every claim you intend to print.
  • Fill the brief before sampling. If market, target price, order quantity, and launch date are incomplete — specifically, if two of these four are missing — complete the brief instead of pushing for samples. Sampling against an unclear brief produces unlimited rework, not speed.

Decision tree: is this project ready to issue a PO?

  • Start here: Is the first-sale market fixed in writing? No → stop; micro limits and labeling are market-specific and cannot be approximated.
  • Yes → Is the product classified (rinse-off / leave-on; baby / child; cosmetic vs. any other category)? No → classify before formula lock.
  • Classified → Does the formula have a version number and a frozen preservative system? No → freeze it; testing on a moving formula is wasted money.
  • Frozen → Do you have stability, microbiological, and preservative efficacy data at the intended shelf life and pack? No → run them; do not release the PO on an interim readout.
  • Yes → Is the container-closure combination fixed, with a compatibility report and a retained golden sample? No → run compatibility before the pilot, not after.
  • Yes → Is every label claim traced to a document by evidence ID? No → hold artwork approval.
  • Yes → PO can be issued with a documented change-control clause.
  • Boundary cases: claims such as “hypoallergenic” or “clinically proven,” any implied therapeutic or developmental benefit, fragrance in a product marketed for infants, and any market where notification or registration is required — escalate to your regulatory lead and, where needed, specialist counsel before the label is designed, not after.

The specification blocks to agree, parameter by parameter

1. Product identity, classification and market

State the exact SKU name, dose form, intended user age band, rinse-off or leave-on status, first-sale market, and the legal responsible entity. These five fields drive everything downstream. A product classified as leave-on will usually face stricter microbiological and preservative expectations than the same formula used as a rinse-off wash.

2. Formula, ingredient control and fragrance

  • Attach the full ingredient list with INCI names, functions, and percentages or ranges, plus the formula version number the tests refer to.
  • Confirm the surfactant system, pH target, and any “tear-free” design intent in writing, because the ocular mildness claim depends on the surfactant blend and pH, not on marketing language.
  • For fragrance: obtain the IFRA certificate and the allergen declaration, and state whether the product is fragrance-free or unscented — these are not interchangeable, and the choice affects allergen labeling and stability.
  • Screen restricted and prohibited substances against the destination market before sampling, not before shipping.

3. Microbiological limits and preservative efficacy

Do not accept “we follow standard limits.” The limit must be named, with the method and the CFU threshold. For China, the reference is the current Cosmetic Safety Technical Specification: total aerobic microbial count ≤1000 CFU/g or mL, total yeast and mold ≤100 CFU/g or mL, and E. coli/coliform, P. aeruginosa, and S. aureus absent. For the EU and other markets, limits are risk-based and set per the applicable product specification and ISO 17516. Pair the micro limits with a preservative efficacy test (ISO 11930 or the market-accepted equivalent) on the final formula in the final pack.

4. Physical and sensory parameters

Specify pH range, viscosity with the measurement conditions (spindle, speed, temperature), appearance, color, odor, and specific gravity, each with a tolerance band and a test method. A viscosity figure without a method is not a specification — it is a number that will cause a batch dispute at goods-in inspection.

5. Safety, irritation and claim substantiation

Agree the test package before the formula is finalized, because the panel size and duration drive the timeline. Note that testing on infants is ethically and legally constrained in most markets; expect in-vitro ocular models, adult sensitive-skin panels, and ophthalmologist-supervised protocols instead, and confirm what your destination market will accept as support.

6. Primary packaging, compatibility and fill

Fix the combination — bottle, pump or closure, dip tube, gasket, decoration, label, carton, shipper — under a single combination ID, and validate it. Compatibility, leakage, pump or spray function, drop and transport testing, filling-line match, and label adhesion are all part of the specification, not optional extras. Retain a golden sample with photos, drawings, and the supplier version of each component.

7. Documentation, traceability and release

The COA must show product, SKU, batch, manufacture date, the specification version it is measured against, test items with results and units, acceptance criteria, method identification where applicable, and quality release authorization. A COA is a single batch’s result record — it never substitutes for the versioned product specification. Build a BOM that lists every component number, the combination approval number, total packaging cost, the MOQ bottleneck, and the longest lead-time item.

Specification summary table

Parameter What to write on the spec sheet Decision point / example Evidence that proves it
Market & classification First-sale country, rinse-off/leave-on, age band, responsible entity Must be fixed before formula lock Signed market-to-product brief
Microbiological limits TAMC, TYMC, specified pathogens, method China: ≤1000 / ≤100 CFU, pathogens absent; EU: per spec + ISO 17516 Batch micro report, method statement
Preservative efficacy Method, criteria, formula version tested ISO 11930 criteria A or B Challenge test report on final formula
pH Target ± tolerance, method, temperature Typically mildly acidic to near-neutral for baby rinse-off COA at t=0 plus stability timepoints
Viscosity Value range with spindle, speed, temperature Must match filling line capability COA plus filling trial record
Irritation / ocular mildness Test type, panel, endpoint, claim supported In-vitro ocular model + adult sensitive-skin panel Signed study reports with protocol numbers
Fragrance & allergens Fragrance-free vs unscented, IFRA status, allergen list Declare all label-relevant allergens IFRA certificate, allergen declaration
Packaging combination Combination ID, all component numbers, decoration Stock vs semi-custom vs custom mold Compatibility, leak, drop and label adhesion reports
Claims Approved wording list with evidence ID per claim “Hypoallergenic” needs a market-specific basis; a patch test alone is not sufficient Claim matrix plus underlying study or safety file
Release documents COA, SDS, specification, stability, batch record COA must cite the correct spec version Document pack issued with each batch

Evidence pack to request before signing

  • Versioned product specification sheet — states every parameter, tolerance, and method. Acceptance: version number and issue date printed; matches the formula version under test.
  • Stability report — accelerated and, where available, real-time data in the final pack. Acceptance: covers pH, viscosity, color, odor, and micro at each timepoint; conclusion states the supported shelf life.
  • Microbiological and preservative efficacy reports — Acceptance: named method, named limits, results in CFU, pass/fail statement signed by the lab.
  • Safety and irritation file — Acceptance: protocol, panel size, duration, endpoint, and the specific claim the study is allowed to support.
  • Packaging compatibility and leak report — Acceptance: tested the exact combination ID at defined temperature and duration; includes pump dose consistency and label adhesion.
  • Packaging BOM — Acceptance: every component number, combination approval number, MOQ bottleneck, and longest lead-time item identified.
  • Claim matrix — Acceptance: each printed claim mapped to an evidence ID and a market review status.
  • COA template plus one real batch COA — Acceptance: batch-level data with spec version, results, units, and release authorization.
  • SDS and transport classification — Acceptance: current version aligned to the shipped formula and pack.
  • Golden sample record — Acceptance: retained sample, photos, drawings, and component supplier versions on file.

Red lines: what not to cut

  • Do not cut the preservative efficacy test or substitute an ingredient-level statement for a finished-product challenge test. A preservative that works in theory and fails in your surfactant base is a recall, not a saving.
  • Do not cut packaging compatibility testing because the bottle is a stock mold. Stock molds still interact with your formula, your filling line, and your transport route.
  • Do not cut stability timepoints to hit a launch date. Compress the artwork cycle instead.
  • Do not print “hypoallergenic,” “clinically proven,” “pediatrician tested,” or “tear-free” without a documented, market-reviewed basis. For “hypoallergenic,” a patch test alone is insufficient. For “clinically proven,” the study must test the finished product for the exact benefit claimed — an ingredient study is not product proof.
  • Do not accept a COA without a specification version, and do not treat a COA as the product specification.
  • Do not skip the market decision to save a week. It determines the micro limits you will be measured against.

Timeline: two realistic paths

Phase Fastest safe path Standard path Buyer action Manufacturer action Evidence output
Brief and market lock Week 0 Week 0–1 Confirm market, price band, quantity, launch date Classification and feasibility check Market-to-product brief
Formula and spec draft Week 1–2 Week 2–4 Approve formula version and preservative system Draft specification with tolerances Version 0.1 spec sheet
Packaging route and compatibility start Week 1–3 (parallel) Week 3–5 Choose stock, semi-custom, or mold; approve combination Compatibility, leak and pump-dose trials Compatibility report, combination ID
Stability, micro and preservative efficacy Week 2–10 Week 4–14 Freeze the formula; no changes during testing t=0, interim and final timepoints Stability and PET reports
Safety and claim testing Week 4–10 Week 6–14 Approve claim list and target wording Commission in-vitro and panel studies Signed study reports, claim matrix
Artwork and claims review Week 8–10 Week 10–16 Review label against claim matrix line by line Cross-check INCI, allergens, warnings, market text Approved artwork, release record
Pilot run and filling trial Week 10–12 Week 14–20 Attend or review pilot report and retain samples Pilot batch, filling-line match, drop test Pilot report, golden sample
Final documentation and PO release Week 12–14 Week 18–24 Verify document pack before releasing the PO Handoff of spec, COA template, SDS, stability, BOM Complete document pack, signed PO

What can be compressed: artwork cycles, pilot scheduling, parallel compatibility work, and review meetings. What cannot: preservative efficacy readouts, microbiological incubation, stability timepoints, and the safety panel duration. Attempting to compress those converts a launch delay into a recall risk.

Common failure modes in baby care sourcing

1. Pump delivers inconsistent dose or leaks in transit

  • Symptom: uneven dosing, product residue on the carton, or leakage in the shipper after transport simulation.
  • Root cause: the pump or valve was chosen for appearance or cost, and never validated against the actual viscosity and fill volume.
  • Prevention: validate the exact container-closure combination with your formula’s viscosity and pH, including drop and transport simulation.
  • What to request from the factory (evidence): compatibility and leak report naming the combination ID, pump dose consistency data, and the filling-line trial record.

2. Label lifting or plastic stress-cracking around the shoulder

  • Symptom: label edges lift after four to six weeks, or fine cracks appear near the neck.
  • Root cause: fragrance or solvent interaction with the container resin, or an adhesive selected without compatibility testing.
  • Prevention: test the decorated pack, not just the bare bottle, at elevated temperature for the labeled duration.
  • What to request from the factory (evidence): label adhesion and compatibility report on the decorated pack, plus the packaging supplier’s material statement.

3. Documentation pack arrives incomplete or inconsistent

  • Symptom: COA without a spec version, missing stability or micro report, or an INCI list that differs between the artwork and the specification.
  • Root cause: documents are compiled at shipment instead of being generated per batch from a controlled specification.
  • Prevention: make the document pack a PO release condition, not a shipping request, and require a single controlled spec version across all documents.
  • What to request from the factory (evidence): full release pack — COA with batch and spec version, SDS, stability, micro, and the approved artwork with INCI.

4. pH drift invalidates the mildness claim

  • Symptom: pH moves outside the stated band at the three-month timepoint, and the tear-free positioning becomes hard to defend.
  • Root cause: no buffer capacity in the formula, or an initial range set too narrowly for the manufacturing process.
  • Prevention: set the pH band from stability data on the pilot-scale batch, not from a single lab batch.
  • What to request from the factory (evidence): pH at t=0, interim, and final timepoints across at least two batches.

5. Preservative system fails on the finished base

  • Symptom: challenge test passes at criteria B but fails the stricter target, or recovers organisms at the final timepoint.
  • Root cause: preservative efficacy assessed on a simplified base rather than the final surfactant or emulsion system.
  • Prevention: run the challenge test on the frozen formula version, at the intended pH.
  • What to request from the factory (evidence): full challenge test report with organism list, timepoints, log reductions, and the formula version tested.

6. Claim challenge at retail or on platform

  • Symptom: a marketplace or retailer requests substantiation for “hypoallergenic” or “clinically proven,” and the file contains an ingredient study or a single patch test.
  • Root cause: claims were drafted by marketing and reviewed after printing.
  • Prevention: build a claim matrix with evidence IDs, and route every claim through market review before artwork approval.
  • What to request from the factory (evidence): claim matrix mapping each printed claim to a document ID, plus the finished-product study report where the claim is clinical.

7. Micro specification assumed, not agreed

  • Symptom: batch results are judged against the wrong limits at goods-in, or filing is questioned because the test method does not match the destination market.
  • Root cause: the specification said “standard limits” instead of naming the market, the CFU thresholds, and the method.
  • Prevention: write the numeric limits and the method into the specification before the first batch.
  • What to request from the factory (evidence): the microbiological specification page with limits, methods, and the market reference stated explicitly.

8. MOQ or lead time discovered after the PO

  • Symptom: the selected pump or custom cap cannot be supplied at the ordered quantity, or its lead time is longer than the fill window.
  • Root cause: the BOM was assembled commercially after the packaging route was aesthetically approved.
  • Prevention: review the BOM for MOQ bottlenecks and longest lead-time items during packaging route selection.
  • What to request from the factory (evidence): BOM with component numbers, MOQ per component, longest lead-time item flagged, and the combination approval number.

Copy-paste checklist to send your supplier

Share the first-sale market, product classification (rinse-off/leave-on) and age band.
Confirm the legal responsible entity for that market in writing.
Provide the versioned product specification sheet with tolerances and test methods.
Attach the full INCI list and the formula version number referenced by all testing.
Lock the preservative system and state the permitted substitution rules, if any.
Confirm the microbiological limits, CFU thresholds and the test method for this market.
Provide the preservative efficacy report on the final formula version.
Fill the stability protocol: timepoints, conditions, pack, and parameters monitored.
Attach pH and viscosity data with method, spindle, speed and temperature.
Confirm whether the product is fragrance-free or unscented, and provide the allergen declaration.
Provide the IFRA certificate if a fragrance compound is used.
List every claim intended for the label with an evidence ID per claim.
Confirm which claims have completed market review and which are still open.
State the safety and irritation test package proposed to support those claims.
Provide the packaging BOM with all component numbers and the combination ID.
Attach the compatibility, leak, pump-dose, drop and label adhesion reports.
Confirm the filling-line match and the pilot run schedule.
Identify the MOQ bottleneck and the longest lead-time item.
Provide a real batch COA and the COA template with spec version fields.
Confirm SDS and transport classification will be issued before shipment.
State the change-control process for formula, pack or supplier changes post-PO.
Confirm the golden sample will be retained with photos, drawings and supplier versions.
Agree the document pack that must be delivered before PO release, not before shipment.
Approve artwork only after the claim matrix is signed off.

FAQ

Can a COA replace the product specification sheet?

No. A COA records one batch’s measured results against a specification. The specification defines the parameters, tolerances, and methods, and it is version-controlled. A COA that does not cite the correct specification version is not usable evidence of conformity.

Is a patch test enough to support a “hypoallergenic” claim?

No. Patch testing alone does not establish a hypoallergenic basis, because the claim carries an implied allergy-risk message that must be supported by market-specific evidence and market review. Treat this claim as high risk and confirm the acceptable basis for your destination market before printing.

When should compliance documentation work start?

At project kickoff. Market, responsible entity, formula, BOM, claims, and documentation gaps should be confirmed at the start; restricted substances, fragrance allergens, and label direction should be pre-screened during sampling; final documents, label approval, notification, and transport classification should be complete before mass production.

Our packaging is a stock bottle — do we still need compatibility testing?

Yes. Stock molds still interact with your formula, decoration, filling line, and transport route. Compatibility, leak, pump-dose, drop, and label adhesion validation apply to the exact combination, regardless of whether the mold is shared or proprietary.

What if we have not decided on the market yet?

Then do not issue the PO. Microbiological limits, labeling obligations, allergen declaration, and claim review are all market-dependent, and a specification written without a market will need to be rebuilt — along with the testing that supported it.

To move from checklist to quotation, send us your target markets, SKU list and formats, brand positioning, packaging direction, and launch timeline. Projects with a fixed market and a frozen brief typically reach a costed, testable specification fastest — Request a Quote.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).